文献速递神经MR

异柠檬酸脱氢酶野生型胶质母细胞瘤中2-羟基戊二酸MR波谱假阳性测量:多因素分析

False-Positive Measurement at 2-Hydroxyglutarate MR Spectroscopy in Isocitrate Dehydrogenase Wild-Type Glioblastoma: A Multifactorial Analysis.
PubMed 文献 · Radiology · 2019-04-16

本回顾性研究纳入82例病理确诊的IDH野生型胶质母细胞瘤患者,评估MR波谱测量2HG的假阳性率及其相关因素。结果显示假阳性率为21%,坏死(>20%者50% vs ≤20%者15%)和ADC值及治疗前状态(46% vs 治疗后14%)与假阳性率升高相关;17例假阳性中15例乳酸≥2.0 mmol/L。

要点

  • IDH野生型胶质母细胞瘤中2HG MR波谱假阳性率为21%(17/82)。
  • 坏死>20%者假阳性率50%,高于坏死≤20%者的15%(P = .01)。
  • 治疗前患者假阳性率46%,高于治疗后患者的14%(P < .01)。

核心结论

  • 坏死和表观扩散系数与IDH野生型胶质母细胞瘤MR波谱2HG假阳性测量相关。

研究设计与样本

  • 回顾性研究,经机构审查委员会批准并豁免知情同意,纳入2017年12月至2018年8月连续82例病理确诊的治疗前和治疗后胶质母细胞瘤患者(平均年龄55岁±12,40例男性)。
  • 采用单体素点分辨波谱获取包括2HG测量在内的波谱参数,并计算表观扩散系数(ADC)值。
  • 根据感兴趣区内坏死比例对坏死进行分级,采用泊松回归分析确定与2HG假阳性测量相关的因素。

关键影像表现/征象

  • 坏死>20%者2HG假阳性率为50%,坏死≤20%者为15%(P = .01)。
  • 治疗前胶质母细胞瘤患者2HG假阳性率为46%,治疗后患者为14%(P < .01)。

诊断标准与关键数值

  • IDH野生型胶质母细胞瘤患者中2HG测量的假阳性率为21%(17/82;95% CI:13%,31%)。
  • 多变量分析显示坏死(患病率比[PR] 3.9;95% CI:1.6,9.4;P = .01)和ADC值(PR 0.1×10⁻³ mm²/sec;95% CI:[0.0,0.7]×10⁻³ mm²/sec;P = .02)与2HG测量假阳性率升高相关。
  • 17例假阳性患者中,15例(88%;95% CI:64%,99%)乳酸浓度≥2.0 mmol/L,14例(82%;95% CI:57%,96%)乳酸浓度≥3.0 mmol/L。

临床应用与阅片要点

  • 解读IDH野生型胶质母细胞瘤的2HG MR波谱时,需结合坏死比例(>20%)和ADC值评估假阳性可能。
  • 治疗前患者及病灶乳酸浓度≥2.0 mmol/L时,2HG假阳性率较高。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

Background Isocitrate dehydrogenase (IDH) mutation has become one of the most important prognostic biomarkers in glioma management. Measurement of 2-hydroxyglutarate (2HG) with MR spectroscopy has shown high pooled sensitivity, although false-positive results with MR spectroscopy have been reported. Purpose To investigate factors associated with false-positive 2HG measurements at MR spectroscopy in patients with IDH wild-type glioblastoma. Materials and Methods This retrospective study was approved by the institutional review board, and informed consent was waived. Consecutive patients with histopathologically confirmed pre- and posttreatment glioblastoma were evaluated between December 2017 and August 2018. Spectroscopy parameters, including 2HG measurements, were obtained with single-voxel point-resolved spectroscopy, and apparent diffusion coefficient (ADC) values were calculated. Necrosis was graded according to the proportion of necrosis within a volume of interest. Poisson regression analyses were performed to determine factors related to false-positive 2HG measurements. Results A total of 82 patients were included (mean age, 55 years ± 12 [standard deviation]; 40 men). The 2HG measurement showed a false-positive rate of 21% (17 of 82; 95% CI: 13%, 31%) in patients with IDH wild-type glioblastoma. Multivariable analysis revealed that necrosis (prevalence ratio [PR], 3.9; 95% CI: 1.6, 9.4; P = .01) and ADC value (PR, 0.1 × 10-3 mm2/sec; 95% CI: [0.0, 0.7] × 10-3 mm2/sec; P = .02) were associated with a greater false-positive rate for the 2HG measurement. Necrosis of more than 20% was associated with a higher rate of false-positive 2HG measurements (50%) than was necrosis of 20% or less (15%, P = .01). The 2HG false-positive rate was higher in patients with pretreatment glioblastoma (46%) than in those with posttreatment glioblastoma (14%, P < .01). Among 17 patients with false-positive findings, 15 (88%; 95% CI: 64%, 99%) had a lactate concentration of 2.0 mmol/L or higher, and 14 (82%, 95% CI: 57%, 96%) had a lactate concentration of 3.0 mmol/L or higher. Conclusion Necrosis and apparent diffusion coefficient were associated with false-positive measurements of 2-hydroxyglutarate at MR spectroscopy in patients with isocitrate dehydrogenase wild-type glioblastoma. © RSNA, 2019 Online supplemental material is available for this article.

来源:Radiology,查看原文。版权归原作者所有。

引用

  1. Suh CH, Kim HS, Paik W, et al. False-Positive Measurement at 2-Hydroxyglutarate MR Spectroscopy in Isocitrate Dehydrogenase Wild-Type Glioblastoma: A Multifactorial Analysis. Radiology. 2019. PMID: 30990380. doi:10.1148/radiol.2019182200

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。